Daniel J. Moorhead net worth and biography

Daniel Moorhead Biography and Net Worth

CFO of Beyond Air

Dan Moorhead brings more than 20 years of finance leadership experience across both public and private companies.

From June 2017 to August 2025, Dan served as Chief Financial Officer of Zynex, Inc., a publicly traded, commercial-stage medical device company, where he implemented a disciplined budgeting and forecasting framework and supported the company's multi-year commercial expansion. Prior to Zynex, Mr. Moorhead spent 10 years at Evolving Systems, Inc. (acquired by PartnerOne, Inc.), serving as Chief Financial Officer following earlier roles as Vice President of Finance & Administration and Corporate Controller.

Mr. Moorhead is a CPA and holds a B.B.A. in Accounting from the University of Northern Colorado.

What is Daniel J. Moorhead's net worth?: The estimated net worth of Daniel J. Moorhead is at least $9.59 thousand as of July 29th, 2026. Moorhead owns 4,340 shares of Beyond Air stock worth more than $9,587 as of October 9th. This net worth estimate does not reflect any other assets that Moorhead may own. Learn More about Daniel J. Moorhead's net worth.
How do I contact Daniel J. Moorhead?: The corporate mailing address for Moorhead and other Beyond Air executives is 900 Stewart Avenue, Suite 301, Garden City, NY, 11530. Beyond Air can also be reached via phone at (516) 665-8200 and via email at [email protected]. Learn More on Daniel J. Moorhead's contact information.
Has Daniel J. Moorhead been buying or selling shares of Beyond Air?: Daniel J. Moorhead has not been actively trading shares of Beyond Air during the last quarter. Most recently, on Wednesday, July 29th, Daniel J. Moorhead bought 4,340 shares of Beyond Air stock. The stock was acquired at an average cost of $5.76 per share, with a total value of $24,998.40. Following the completion of the transaction, the chief financial officer now directly owns 4,340 shares of the company's stock, valued at $24,998.40. Learn More on Daniel J. Moorhead's trading history.
Who are Beyond Air's active insiders?: Beyond Air's insider roster includes Amir Avniel (COO), Douglas Beck (CFO), Ron Bentsur (Director), Robert Carey (Director), Michael Gaul (COO), Robert Goodman (CEO), Steven Lisi (CEO), Erick Lucera (Director), and Daniel Moorhead (CFO). Learn More on Beyond Air's active insiders.
Are insiders buying or selling shares of Beyond Air?: In the last year, Beyond Air insiders bought shares 2 times. They purchased a total of 39,062 shares worth more than $224,997.12. The most recent insider tranaction occured on July, 29th when CEO Robert Scott Goodman bought 34,722 shares worth more than $199,998.72. Insiders at Beyond Air own 10.0% of the company. Learn More about insider trades at Beyond Air.
Information on this page was last updated on 7/29/2026.

Daniel J. Moorhead Insider Trading History at Beyond Air

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/29/2026	Buy	4,340	$5.76	$24,998.40	4,340

Daniel J. Moorhead Buying and Selling Activity at Beyond Air

Beyond Air Company Overview

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Today's Range

Now: $2.25

$2.20

$2.34

50 Day Range

MA: $4.13

$2.31

$6.92

2 Week Range

Now: $2.25

$2.20

$55.00

Volume

64,163 shs

Average Volume

197,982 shs

Market Capitalization

$2.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.21